Download
s00432-021-03625-3.pdf 904,62KB
WeightNameValue
1000 Titel
  • Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements
1000 Autor/in
  1. Wolf, Clemens |
  2. Rachow, Tobias |
  3. Ernst, Thomas |
  4. Hochhaus, Andreas |
  5. Zomorodbakhsch, Bijan |
  6. Foller, Susan |
  7. Rengsberger, Matthias |
  8. Hartmann, Michael |
  9. Hübner, Jutta |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-17
1000 Erschienen in
1000 Quellenangabe
  • 148(2):461-473
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00432-021-03625-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800918/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!The aim of our study was to analyse the frequency and severity of different types of potential interactions in oncological outpatients' therapy. Therefore, medications, food and substances in terms of complementary and alternative medicine (CAM) like dietary supplements, herbs and other processed ingredients were considered.!##!Methods!#!We obtained data from questionnaires and from analysing the patient records of 115 cancer outpatients treated at a German university hospital. Drug-drug interactions were identified using a drug interaction checking software. Potential CAM-drug interactions and food-drug interactions were identified based on literature research.!##!Results!#!92.2% of all patients were at risk of one or more interaction of any kind and 61.7% of at least one major drug-drug interaction. On average, physicians prescribed 10.4 drugs to each patient and 6.9 interactions were found, 2.5 of which were classified as major. The most prevalent types of drug-drug interactions were a combination of QT prolonging drugs (32.3%) and drugs with a potential for myelotoxicity (13.4%) or hepatotoxicity (10.1%). In 37.2% of all patients using CAM supplements the likelihood of interactions with medications was rated as likely. Food-drug interactions were likely in 28.7% of all patients.!##!Conclusion!#!The high amount of interactions could not be found in literature so far. We recommend running interaction checks when prescribing any new drug and capturing CAM supplements in medication lists too. If not advised explicitly in another way drugs should be taken separately from meals and by using nonmineralized water to minimize the risk for food-drug interactions.
1000 Sacherschließung
lokal Surveys and Questionnaires [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Food-Drug Interactions/physiology [MeSH]
lokal Complementary and alternative medicine
lokal Aged [MeSH]
lokal Dietary Supplements/statistics
lokal Original Article – Clinical Oncology
lokal Neoplasms/epidemiology [MeSH]
lokal Germany/epidemiology [MeSH]
lokal Male [MeSH]
lokal Cancer outpatients
lokal Neoplasms/pathology [MeSH]
lokal Drug–drug interactions
lokal Drug Interactions [MeSH]
lokal Herbal Medicine [MeSH]
lokal Food–drug interactions
lokal Cancer treatment
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Complementary Therapies/statistics
lokal Plant Extracts/therapeutic use [MeSH]
lokal Adult [MeSH]
lokal Dietary Supplements/adverse effects [MeSH]
lokal Phytotherapy/methods [MeSH]
lokal Humans [MeSH]
lokal Plants, Medicinal/adverse effects [MeSH]
lokal Retrospective Studies [MeSH]
lokal Middle Aged [MeSH]
lokal Polypharmacy/statistics
lokal Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH]
lokal Neoplasms/drug therapy [MeSH]
lokal Phytotherapy/adverse effects [MeSH]
lokal Young Adult [MeSH]
lokal Chemotherapy
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-5429-2008|https://frl.publisso.de/adhoc/uri/UmFjaG93LCBUb2JpYXM=|https://frl.publisso.de/adhoc/uri/RXJuc3QsIFRob21hcw==|https://frl.publisso.de/adhoc/uri/SG9jaGhhdXMsIEFuZHJlYXM=|https://frl.publisso.de/adhoc/uri/Wm9tb3JvZGJha2hzY2gsIEJpamFu|https://frl.publisso.de/adhoc/uri/Rm9sbGVyLCBTdXNhbg==|https://frl.publisso.de/adhoc/uri/UmVuZ3NiZXJnZXIsIE1hdHRoaWFz|https://frl.publisso.de/adhoc/uri/SGFydG1hbm4sIE1pY2hhZWw=|https://frl.publisso.de/adhoc/uri/SMO8Ym5lciwgSnV0dGE=
1000 Hinweis
  • DeepGreen-ID: 1f36a87d78e0499ba71133ead04628b0 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6449890.rdf
1000 Erstellt am 2023-05-09T10:30:10.630+0200
1000 Erstellt von 322
1000 beschreibt frl:6449890
1000 Zuletzt bearbeitet Sat Oct 21 02:11:53 CEST 2023
1000 Objekt bearb. Sat Oct 21 02:11:53 CEST 2023
1000 Vgl. frl:6449890
1000 Oai Id
  1. oai:frl.publisso.de:frl:6449890 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source